Clinical Trials Logo

Iliac Aneurysm clinical trials

View clinical trials related to Iliac Aneurysm.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05607277 Completed - Clinical trials for Abdominal Aortic Aneurysm

Global Iliac Branch Study

GIBS
Start date: November 2014
Phase:
Study type: Observational

This project seeks to determine if certain anatomic factors, specifically tortuous and non-conformable iliac arteries, may predict device complications, including seal zone failure, type III endoleak, and occlusion. Approximately 400 subjects from 5 academic centers across the United States, Europe, and Asia will be included in this study. Various markers of pre- and post-treatment iliac anatomy will be measured using CT imaging, and clinical events will be reported by academic centers. The relationship of imaging data to patient demographics will then be assessed alongside anatomic and demographic predictors of non-conformability.

NCT ID: NCT03762525 Completed - Angiography Clinical Trials

Iliac Branch Device Movement During Cardiac Cycle (IBD-dynamics)

Start date: October 5, 2016
Phase: N/A
Study type: Interventional

The incidence of isolated common iliac artery (CIA) aneurysms is low, but in combination with an abdominal aortic aneurysm (AAA) they are found in approximately 20-40% of cases. Basically, two different endovascular strategies can be applied to treat a CIA aneurysm with, including 1. the coverage and 2. the preservation of blood flow to the internal iliac artery (IIA). Coil and coverage of the IIA is related to ischemic complications, including buttock claudication, erectile dysfunction and the more severe spinal and colonic ischemia. Iliac branched devices (IBD) have been developed to exclude CIA aneurysms preserving the IIA and currently three alternatives are on the market. Clinical results of these devices are promising but loss of patency is not uncommon. The major difference between the two devices is the IIA component. The Cook IBD uses a -non-dedicated IIA component, while in the GORE® EXCLUDER® Iliac Branch Endoprosthesis (Gore IBE device) a dedicated self expanding stent is used. Stresses and forces exerted onto the endograft by aortic pulsatility may have an effect on the durability and functioning of the endograft. Intermittent hinchpoints could also have an effect on stent integrity and stenosis. By evaluating endograft movement during the cardiac cycle (ECG-gated CTA) it is possible to assess the stress and force exerted onto the endograft. This might help gain insight into mechanisms underlying potential endograft failure, and aid procedural planning and the development of future devices with long-term durability. The choice for device is not part of this study.

NCT ID: NCT03061825 Completed - Clinical trials for Aorto-iliac Aneurysm

Zenith Alpha™ Abdominal Endovascular Graft

Start date: May 24, 2017
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is to evaluate the clinical performance of the Zenith Alpha™ Abdominal Endovascular Graft for the treatment of abdominal aortic or aorto-iliac aneurysm.

NCT ID: NCT02571907 Completed - Iliac Aneurysms Clinical Trials

PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation Clinical Study

Start date: April 1, 2014
Phase: N/A
Study type: Interventional

The purpose of this extended study is to evaluate the safety and effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the commercially available Atrium iCAST™ covered stent in patients in a treatment of aortoiliac and iliac aneurysms.

NCT ID: NCT02535065 Completed - Clinical trials for Abdominal Aortic Aneurysms

Zenith® Low Profile AAA Endovascular Graft

Start date: August 2014
Phase: N/A
Study type: Interventional

The Zenith® Low Profile AAA Endovascular Graft Clinical Study is a clinical trial to study the safety and effectiveness of the Zenith® Low Profile AAA Endovascular Graft used in conjunction with the Zenith® Spiral-Z® AAA Iliac Leg Graft to treat abdominal aortic, aortoiliac, and iliac aneurysms.

NCT ID: NCT02209194 Completed - Iliac Aneurysm Clinical Trials

Post-market Registry in Patients With Iliac Aneurysm Undergoing Endovascular Stenting With the E-liac Stent Graft System

Start date: June 2014
Phase:
Study type: Observational

The purpose of the study is to evaluate the clinical and technical success as well as safety and feasibility of the E-liac Stent Graft System used in endovascular treatment of uni- or bilateral aortoiliac or iliac aneurysm. Main study target is the exclusion of aneurysm with primary patency of the arteria iliaca interna and the arteria iliaca externa on iliac implantation side.

NCT ID: NCT01990950 Completed - Clinical trials for Abdominal Aortic Aneurysm (AAA)

Fenestrated AAA Endovascular Graft Post-Approval Study

Start date: March 2014
Phase: N/A
Study type: Interventional

This post-market study is approved by the US FDA to evaluate the long-term safety and performance of the Zenith® Fenestrated AAA Endovascular Graft.

NCT ID: NCT01883999 Completed - Clinical trials for Aorto-iliac Aneurysms

Evaluation of the GORE® EXCLUDER® Iliac Branch Endoprosthesis

Start date: October 2013
Phase: N/A
Study type: Interventional

The Iliac Branch Endoprosthesis (IBE) 12-04 study will be a prospective, nonrandomized, multicenter, single-arm evaluation designed to assess the safety and efficacy of the IBE Device in subjects with common iliac artery aneurysms (CIAA) or aorto-iliac aneurysms (AIA).

NCT ID: NCT01540643 Completed - Clinical trials for Abdominal Aortic Aneurysm

Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry

Start date: March 2012
Phase: N/A
Study type: Observational

The purpose of this registry is to obtain case reports of physician experience with the Spiral-Z® graft under routine clinical care.

NCT ID: NCT01326884 Completed - Clinical trials for Abdominal Aortic Aneurysm

Zenith Low Profile AAA Endovascular Graft (ZLP) Clinical Study

ZLP
Start date: February 2011
Phase: N/A
Study type: Interventional

A prospective study conducted in Japan to collect confirmatory peri-operative and 30-day information on use of the Zenith LP AAA Graft.